Navigation Links
Global Hyaluronic Acid Market to Grow to $2.5 Billion by 2017
Date:1/28/2013

TORONTO, Jan. 28, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the patient pool for hyaluronic acid (HA) viscosupplementation will continue to expand globally, due to rising rates of osteoarthritis and obesity, leading to moderate growth in the global HA viscosupplementation market to nearly $2.5 billion by 2017.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO )

The most significant treatment trend will continue to be the shift to premium-priced shorter treatment regimens, which offer more convenience for the patient and increase patient compliance with treatment. This trend will occur worldwide. While 5-injection treatments are still the leading choice for patients globally, the number is skewed by Japan, where more than 80 percent of such procedures were performed in 2011. One- and 3-injection treatments will continue to rise as a proportion of total treatments.

While HA viscosupplementation treatments are used primarily in the knee, there will be a shift toward using this treatment for other joints in the body, as physicians become more comfortable performing the procedure on non-knee areas. Manufacturers are investing in non-knee clinical trials to provide support for this shift.

"Despite the diverse competitive landscape for these products, two companies have captured over half the global market," said MRG Analyst Kristina Vidug . "While they both sell in all three major regions, Seikagu is strongest in Asia Pacific, while Sanofi dominates the United States market."

Companies that compete on price, introduce a product that is specific to a non-knee indication or release a single-injection product will be most successful in this market through 2017.

Millennium Research Group's Global Markets for Hyaluronic Acid Viscosupplementation 2013 report includes unit, average selling price and revenue information, along with market drivers and limiters and competitive landscape for HA viscosupplementation in the United States, Europe (France, Germany, Italy, Spain, and the United Kingdom), and the Asia Pacific and emerging markets (Australia, Brazil, China [Mainland China and Hong Kong], India, Japan, South Korea and Taiwan).

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.com

Alex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Health Diagnostic Laboratory, Inc. and Global Genomics Group join forces to form a new scientific process
2. Point of Care Testing Market and Forecast to 2016: Global Analysis
3. Medical Specialty Bags Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
4. Global Brachytherapy Devices Market 2012-2016
5. Global DNA Sequencing Products Market 2012-2016
6. Breakthrough Research Could Create Sea Change in Global HIV Diagnosis: New Handheld Mobile Device Performs Laboratory-Quality HIV Testing
7. Life Science Veterans Highlight Opportunities at BIOCOM 3rd Annual Global Partnering Conference
8. Global Medical Device Marketing Groups Respond to Internal Cost Pressures
9. Pharmaceuticals: Global Industry Guide
10. Global Biosimilars: A return to optimism?
11. Global Bariatric (Obesity) Surgical Devices Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):